Please login to the form below

Not currently logged in
Email:
Password:

Horizon

This page shows the latest Horizon news and features for those working in and with pharma, biotech and healthcare.

UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns

UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns

Horizon Europe and cuts to research funded by Official Development Assistance – a move which the peers said had already damaged the UK’s international reputation.

Latest news

More from news
Approximately 18 fully matching, plus 156 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest appointments

  • CureVac’s CEO appointed to EC High Level Group CureVac’s CEO appointed to EC High Level Group

    Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes. ... Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough, market-creating innovation in the Horizon 2020 project as

  • Decibel Therapeutics expands leadership team Decibel Therapeutics expands leadership team

    He co-founded Bright Horizons Family Solutions, a worksite childcare and early education provider, and prior to this served as co-director of Save the Children's Sudan operations.

  • Eric Rhodes becomes CEO of ERS Genomics Eric Rhodes becomes CEO of ERS Genomics

    Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice president of research and development and chief technology officer. ... Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of

  • Jane Osbourn to chair BIA board Jane Osbourn to chair BIA board

    The new members of the board are Darrin Disley, chief executive of Horizon Discovery Group and David Hipkiss, chief business officer at Circassia Pharmaceuticals.

  • Adaptimmune appoints Lawrence Alleva to its board Adaptimmune appoints Lawrence Alleva to its board

    He currently serves as a director for public companies Tesaro and Bright Horizons Family Solutions, and for the privately-held Mirna Therapeutics, and chairs those companies' audit committees.

More from appointments
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 41 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...